(NASDAQ: QTRX) Quanterix's forecast annual revenue growth rate of 5.92% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.51%.
Quanterix's revenue in 2026 is $153,409,000.On average, 5 Wall Street analysts forecast QTRX's revenue for 2026 to be $6,937,892,636, with the lowest QTRX revenue forecast at $6,598,328,429, and the highest QTRX revenue forecast at $7,225,434,471. On average, 5 Wall Street analysts forecast QTRX's revenue for 2027 to be $7,625,533,801, with the lowest QTRX revenue forecast at $7,254,283,240, and the highest QTRX revenue forecast at $7,910,710,983.
In 2028, QTRX is forecast to generate $8,683,479,665 in revenue, with the lowest revenue forecast at $8,172,241,632 and the highest revenue forecast at $9,186,677,876.